Andy
Senior Member (Voting rights)
Finding solutions to long covid will require new ways of thinking across clinical services and research, says Amitava Banerjee
William Osler famously said, “Listen to the patient, he is telling you the diagnosis.” For long covid, patients have not only told us the diagnosis since April 2020, but also gave a clear steer as to how we should proceed with this new disease: “recognition, research, and rehabilitation.”1 We have made mixed progress across these areas.
It is not hard to see why we have not always been successful in responding to long covid. From HIV/AIDS to Ebola, emerging disease threats with coordinated international responses are usually acute and infectious. A new chronic condition, albeit as a post-acute complication of SARS-CoV-2 infection, requires new ways of thinking across clinical, public health, policy, and academic disciplines. Whether it be the World Health Organisation (WHO), governments, or research funders, emergency preparedness has tended to exclude chronic and post-infectious disease management, but long covid must change that.
Recognition of a new disease requires it to be classifiable and recordable, facilitating monitoring, research, and treatment. SNOMED CT codes for long covid were developed and released in the UK in November 2020,2 followed by ICD-10 codes and a WHO case definition in June and October of 2021.34 However, the uptake of these codes is still low in the UK2 and worldwide, leading to a systematic underestimation of the disease burden of long covid in routine care, despite high estimated prevalence from self-reported surveys (e.g. 1.7% of the UK population as of 5 September 2021).5
https://www.bmj.com/content/375/bmj.n2736
William Osler famously said, “Listen to the patient, he is telling you the diagnosis.” For long covid, patients have not only told us the diagnosis since April 2020, but also gave a clear steer as to how we should proceed with this new disease: “recognition, research, and rehabilitation.”1 We have made mixed progress across these areas.
It is not hard to see why we have not always been successful in responding to long covid. From HIV/AIDS to Ebola, emerging disease threats with coordinated international responses are usually acute and infectious. A new chronic condition, albeit as a post-acute complication of SARS-CoV-2 infection, requires new ways of thinking across clinical, public health, policy, and academic disciplines. Whether it be the World Health Organisation (WHO), governments, or research funders, emergency preparedness has tended to exclude chronic and post-infectious disease management, but long covid must change that.
Recognition of a new disease requires it to be classifiable and recordable, facilitating monitoring, research, and treatment. SNOMED CT codes for long covid were developed and released in the UK in November 2020,2 followed by ICD-10 codes and a WHO case definition in June and October of 2021.34 However, the uptake of these codes is still low in the UK2 and worldwide, leading to a systematic underestimation of the disease burden of long covid in routine care, despite high estimated prevalence from self-reported surveys (e.g. 1.7% of the UK population as of 5 September 2021).5
https://www.bmj.com/content/375/bmj.n2736